New Key Statistics Module, Z-Score and F-Score
SHSE:688621 Key Ratios
Market Cap ¥ M | 4,734.24 |
Enterprise Value ¥ M | 4,590.34 |
P/E(ttm) | 21.46 |
PE Ratio without NRI | 16.75 |
Forward PE Ratio | 15.61 |
Price/Book | 4.19 |
Price/Sales | 4.10 |
Price/Free Cash Flow | 38.33 |
Price/Owner Earnings | 29.32 |
Payout Ratio % | 0.07 |
Revenue (TTM) ¥ M | 1,156.00 |
EPS (TTM) ¥ | 1.97 |
Beneish M-Score | -2.12 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 41.80 |
y-y EBITDA Growth Rate % | 9.60 |
EV-to-EBIT | 18.58 |
EV-to-EBITDA | 18.58 |
PEG | 0.40 |
Shares Outstanding M | 112.00 |
Net Margin (%) | 19.14 |
Operating Margin % | 26.48 |
Pre-tax Margin (%) | 19.96 |
Quick Ratio | 1.86 |
Current Ratio | 1.88 |
ROA % (ttm) | 11.58 |
ROE % (ttm) | 20.90 |
ROIC % (ttm) | 23.99 |
Dividend Yield % | 0.39 |
Altman Z-Score | 4.80 |
SHSE:688621 Number of Guru Trades
SHSE:688621 Volume of Guru Trades
Gurus Latest Trades with SHSE:688621
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688621 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Beijing Sun-Novo Pharmaceutical Research Co Ltd Insider Transactions
No Available Data